Disclosures: Anna Goebel: Nothing to Disclose, Emily Sheng: Nothing to Disclose, Pedro Ochoa-Allemant: Nothing to Disclose, Nadim Mahmud: Nothing to Disclose 933 RACIAL AND ETHNIC DISPARITIES IN LIVER CANCER RISK BY BIRTH COHORT: AN ELECTRONIC HEALTH RECORD (EHR)-BASED EPIDEMIOLOGIC COHORT STUDY Chanda Ho 1 Janet Chu 2 Aly Cortella 2 Alison Canchola 2 Pushkar Inamdar 2 Pragati Kenkare 3 Jane Vu 3 Sixiang Nie 4 Ma Somsouk 5 Michele Tana 5 Caroline Thompson 6 Scarlett Gomez 2 Hashem El-Serag 7 Miok Kim 2 Mark Segal 2 Yihe Daida 4 Su-Ying Liang 3 Mindy Hebert-Derouen 2 Salma Shariff-Marco 2 , 1 Singapore General Hospital, 2 University of California San Francisco, 3 Sutter Health, 4 Kaiser Permanente Hawaii, 5 San Francisco General Hospital, 6 University of North Carolina, 7 Baylor College of Medicine Background: Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related death in the United States
Variations in genes controlling lipid pathwayssuch as those affecting apolipoprotein production, cholesterol absorption, and triglyceride synthesisinfluence whether you experience modest or substantial improvements in your cholesterol panel
The FDA determined the tirzepatide injection shortage was resolved on December 19, 2024
Target 30 to 50 grams of protein per meal, three to four meals daily
